
COSO 2013 Framework vs. ERM Framework: Implementation Challenges and Opportunities
Sonia Luna
90 Min
Product Id: 703415
This webinar will explain similarities and differences between COSO v ERM frameworks. Attendees will understand key advantages of using the ERM framework over the updated COSO 2013 model.

Adverse Event Reporting Requirements for Dietary Supplements and OTC Drugs
Mukesh Kumar
90 Min
Product Id: 703422
This webinar will discuss regulatory requirements for adverse event reporting for dietary supplements and OTC products. It will explain the similarities and differences in reporting adverse events for dietary supplements and OTC products and will also discuss trends in FDA audit for these products.

Effective Coaching for Sustainable Peak Performance
Gail Birks
60 Min
Product Id: 703425
This webinar will help you enhance your current strategies of coaching employees & teams for sustainable peak performance. You will be given that are designed for effective coaching, defining roles, measuring performance & implementing plans.

The New European Union Clinical Trials Regulation: An Analysis of the Key Changes and their Implications for Future Clinical Trials
Ciara Farrell,Elisabethann Wright
60 Min
Product Id: 703445
This webinar will review the changes introduced by the new European Union ("EU") Clinical Trials Regulation and the implications for future clinical trials.

OSHA Refresher Course - Electrical Safety Compliance
Leo Muckerheide
90 Min
Product Id: 702424
This webinar will help you understand the applicable electrical safety practices in the workplace and review the responsibilities and requirements for a person qualified in the OSHA and National Fire Protection Association’s (NFPA) standards.

LDT including CDx; CLIA versus FDA's Authority
Abdel Halim
60 Min
Product Id: 703399
This webinar will explain the regulatory path of an in vitro diagnostic (IVD) and Laboratory Developed Test (LDT). It will discuss the CLIA regulations for Laboratory Developed Tests (LDTs), including companion diagnostics (CDx) and how these differ from the FDA’s authority.

How to respond to GXP (GCP, GLP, GMP, GPV) Inspection and Audit Findings using Correction and Preventative Action (CAPA)
Laura Brown
60 Min
Product Id: 703160
This webinar will help attendees understand how to respond to inspection and audit findings using CAPA (Correction and Preventative Action) for all types of GXP inspections and audit (eg GCP, GLP, GMP, GPV).

Business Associate Agreements (BAA): Why the Pushback from Business Associates
Tom Dumez
60 Min
Product Id: 703397
This webinar will explain the requirements of the Omnibus Final Rule regarding Business Associate Agreements (BAA’s) including what it was, what it is now, and what it might be in the future. It will discuss responsibility, liability, indemnification, injunctive relief, and other topics that are causing, or may be causing, contention.

Understanding OSHA - Avoiding Citations and Preparing for the Unexpected
Paul Gogulski PE
90 Min
Product Id: 703419
This webinar will explain how to prepare for an unannounced OSHA inspection and avoid citations and fines. Attendees will learn how to effectively use Job Hazard Analysis (JHA) to prevent accidents in the workplace.

Medical Device Excise Tax
Daniel O Leary
90 Min
Product Id: 703114
This webinar explains the excise tax on medical device manufactures that went into effect on January 1, 2013, including the devices it covers and the effective selling price for tax purposes.

Overview of the Medical Device Risk Management Standard-ISO 14971
Edwin L Bills
90 Min
Product Id: 700524
This medical device risk management webinar will provide attendees an overview of ISO 14971requirements and practical tips for implementing an effective system for managing risk. It will also discuss differences between the world-wide international standard ISO 14971:2007 and the Europe-only version risk management standard EN ISO 14971:2012.

CMC Considerations for INDs and NDAs for 505(b)(2) Products
Mukesh Kumar
90 Min
Product Id: 703393
This webinar will highlight the key elements of the Chemistry, Manufacturing and Controls (CMC) section of an IND and NDA application for a 505(b)(2) product using examples and case studies. It will also discuss role of Drug Master Files (DMFs), and cross reference authorizations.

How to Handle a Whistleblower Retaliation Investigation (From Start to Finish)
Amy Block Joy
60 Min
Product Id: 703418
This webinar will provide strategies to prevent and/or stop retaliation in the workplace. It will discuss how to recognize retaliation before it takes root; best prevention practices and strategies to safeguard employees.

Money Service Businesses (MSB): High Risk Account Type
Rosanna Jacobsen
60 Min
Product Id: 703408
This webinar will highlight the complex efforts in identifying and monitoring of Money Service Businesses (MSB). It will discuss MSB regulatory requirements, documentations, and scenarios that provide guidance on this high risk account type requiring extended due diligence.

CFR 21 Part 11 and Annex 11: How to Avoid the Audit Traps
Chinmoy Roy
75 Min
Product Id: 702279
This webinar on Part 11/Annex 11 audit and enforcement will explain what the auditors are trained to look for during a Part 11/Annex 11 “tag along” audit. It will cover inspection trends with examples of some recent 483s and warning letters and show what one need to do to have a successful inspection outcome.

Overview of Importing Foreign Cosmetic and OTC Products
Marc Sanchez
60 Min
Product Id: 703379
This webinar will cover key definitions like cosmetics, new drugs, adulteration and misbranding, including key concepts like color additive restrictions and labeling requirements. Attendees will learn best practices for responding to Warning Letters.

Document Approval, Control, and Distribution: How to Meet FDA QSR and ISO 13485 Requirements
Jeff Kasoff
60 Min
Product Id: 700254
This presentation will review the QSR and ISO requirements for document control, and provide a streamlined process for document control.

Customer Due Diligence and Enhanced Due Diligence
Burke Files
90 Min
Product Id: 703403
This webinar will explain the process of customer due diligence and enhanced due diligence. It will cover customer onboarding, sources of funds and wealth, customer questionnaires including financial institution’s core competencies.

How to Conduct an FLSA Classification Self-Audit
Max Muller
60 Min
Product Id: 703388
This webinar will explain how to undertake a voluntary self-audit of your organization’s pay practices. Attendees will learn how to determine who is exempt from the overtime provisions of the FLSA and how to document classification decisions.

Implementing Records Management Initiatives
Denise Cicchella
60 Min
Product Id: 703387
This webinar will explain how to implement an effective records management program. Attendees will learn the advantages of record management to ensure safety and security of data.